PureTech Archives -

Digital health player Akili has raised $110 million fourth-round funding, backed by a number of pharma groups, as

Akili raises $110m to build its digital therapeutics pipeline

https://pharmaphorum.com/news/akili-raises-110m-to-build-its-digital-therapeutics-pipeline/

News/ News/ R&D

PureTech begins trial of potential ‘Long COVID’ drug as cases mount

Richard Staines COVID-19, infectious diseases, Long COVID, PureTech, R&D 0 Comment

As the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after

PureTech begins trial of potential ‘Long COVID’ drug as cases mount

https://pharmaphorum.com/news/puretech-begins-trial-of-potential-long-covid-drug-as-cases-mount/

Digital/ News/ News

Akili presents new real-world data from therapeutic ADHD video game

Richard Staines ADHD, Akili, digital therapeutics, PureTech 0 Comment

Akili has new data from its childhood hyperactivity therapeutic video game EndeavorRx, as the company builds a case

Akili presents new real-world data from therapeutic ADHD video game

https://pharmaphorum.com/news/akili-presents-new-real-world-data-from-therapeutic-adhd-video-game/

News/ News/ R&D

PureTech’s Vedanta Biosciences gets federal funding for C. Diff. microbiome therapy

Richard Staines C. diff infections, Ferring Pharma, infectious diseases, PureTech, R&D, Vedanta 0 Comment

US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C.

PureTech’s Vedanta Biosciences gets federal funding for C. Diff. microbiome therapy

https://pharmaphorum.com/news/puretechs-vedanta-biosciences-gets-federal-funding-for-c-diff-microbiome-therapy/

Digital/ News/ News

Akili’s ADHD digital therapy approved in Europe

Richard Staines ADHD, Akili, digital health, neurology, PureTech 0 Comment

The European Medicines Agency has approved Akili’s ground-breaking digital therapy for attention deficit hyperactivity disorder (ADHD), which uses a video

Akili’s ADHD digital therapy approved in Europe

https://pharmaphorum.com/news/akilis-adhd-digital-therapy-approved-in-europe/

Market Access/ News/ News

PureTech unit Follica cues up phase 3 programme for male hair loss

Phil Taylor alopecia, drug devices, Hair Transplant, medical device, PureTech 0 Comment

PureTech has said one of the companies it has founded – Follica – is preparing to start registration

PureTech unit Follica cues up phase 3 programme for male hair loss

https://pharmaphorum.com/news/puretech-unit-follica-cues-up-phase-3-programme-for-male-hair-loss/

R&D/ Views & Analysis/ Views and analysis

Coronavirus news roundup – 29/05/2020

Richard Staines artificial intelligence, coronavirus, COVID-19, Gilead, PureTech, R&D, remdesivir 0 Comment

A series of vaccines and drugs are being fast-tracked through the big pharma pipeline as part of a

Coronavirus news roundup – 29/05/2020

https://pharmaphorum.com/views-and-analysis/coronavirus-news-roundup-29-05-2020/

Market Access/ News/ News

FDA approves PureTech’s obesity device Plenity

George Underwood Gelesis, Novo Nordisk, obesity, Plenity, PureTech 0 Comment

The FDA has approved PureTech Health’s ‘space occupying’ device Plenity as a new prescription treatment for obesity, setting

FDA approves PureTech’s obesity device Plenity

https://pharmaphorum.com/news/fda-approves-puretech-obesity-plenity/

News/ News/ R&D

PureTech’s Vedanta raises $27m for microbiome research

George Underwood cancer, investment, microbiome, PureTech, Vedanta 0 Comment

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several

PureTech’s Vedanta raises $27m for microbiome research

https://pharmaphorum.com/news/puretechs-vedanta-raises-27m-for-microbiome-research/

Trending

PureTech

Login